The use of two hepatoma cell lines, Hep3B and HepG2, that exhibit hypoxia-induced Epo gene expression facilitated isolation of the hypoxia-responsive Epo 3′ enhancer (10, 11, 12). The gene discussed is EPO; the disease is hepatocellular carcinoma.